Real-time enrollment status for this transformed splenic marginal zone lymphoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 5:40 AM UTC
| NCT Number | NCT06712459 |
| Recruiting Status | Recruiting |
| Condition | Transformed Splenic Marginal Zone Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 100 participants |
| Active Locations | 1 sites in the US |
| Sponsor | International Extranodal Lymphoma Study Group (IELSG) |
| Last Updated on CT.gov | January 16, 2026 (Jan 16, 2026) |
As of July 18, 2026: Clinical trial NCT06712459 is currently recruiting participants. This clinical trial study for transformed splenic marginal zone lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by International Extranodal Lymphoma Study Group (IELSG). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06712459 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06712459 was last updated Jan 16, 2026 (January 16, 2026). HelloStudys verifies this status automatically.